Page last updated: 2024-11-06

3-methylguanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Methylguanine (3MeG) is a modified guanine base found in DNA. It is formed by the methylation of guanine at the N3 position. 3MeG can be generated by endogenous sources, such as the enzyme S-adenosylmethionine decarboxylase, or by exogenous sources, such as alkylating agents used in chemotherapy. 3MeG can induce mutations and has been implicated in the development of cancer. It is also a substrate for DNA repair enzymes, such as the methylguanine methyltransferase (MGMT) pathway. 3MeG is studied to understand its role in DNA damage and repair, its potential as a biomarker for cancer, and its possible use in developing new therapeutic strategies.'

3-methylguanine : A methylguanine carrying the methyl substituent at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-amino-3-methyl-3,9-dihydro-6H-purin-6-one : A 3-methylguanine that is 3,9-dihydro-6H-purin-6-one substituted by an amino group at position 2 and a methyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-imino-3-methyl-1,2,3,9-tetrahydro-6H-purin-6-one : A 3-methylguanine that is 1,2,3,9-tetrahydro-6H-purin-6-one substituted by an imino group at position 2 and a methyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-amino-3-methyl-3,7-dihydro-6H-purin-6-one : A 3-methylguanine that is 3,7-dihydro-6H-purin-6-one substituted by an amino group at position 2 and a methyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID76292
CHEBI ID46893
CHEBI ID27564
CHEBI ID46892
SCHEMBL ID48433
SCHEMBL ID10379715
MeSH IDM0129925

Synonyms (38)

Synonym
unii-feq5689emb
nsc 62622
feq5689emb ,
guanine, 3-methyl- (van)
6h-purin-6-one, 2-amino-3,7-dihydro-3-methyl-
einecs 220-988-9
nsc-62622
n3-methylguanine
nsc62622
guanine, 3-methyl-
2958-98-7
C02230
2-amino-3,7-dihydro-3-methyl-6h-purin-6-one
3-methylguanine
2-imino-3-methyl-1,2,3,9-tetrahydro-6h-purin-6-one
CHEBI:46893
CHEBI:27564
n(3)-methylguanine
CHEBI:46892
2-amino-3-methyl-3,7-dihydro-6h-purin-6-one
2-amino-3-methyl-3,9-dihydro-6h-purin-6-one
2-amino-3-methyl-7h-purin-6-one
3-meg
AKOS006230273
FT-0648527
SCHEMBL48433
AKOS022636953
SCHEMBL10379715
2-amino-3-methyl-3,7-dihydro-6h-purin-6-one #
XHBSBNYEHDQRCP-UHFFFAOYSA-N
2-amino-3-methyl-6,7-dihydro-3h-purin-6-one
DTXSID90183755
3-methyl-guanine (van) (8ci)
7-dihydro-3-methyl-2-amino-3-6h-purin-6-one
7-dihydro-3-methyl-2-amino-3-6h-purin-6-one (9ci)
Q38133599
2-amino-3,9-dihydro-3-methyl-6h-purin-6-one
6h-purin-6-one, 2-amino-3,9-dihydro-3-methyl-

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" We show that Aag protects against the toxic and clastogenic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and mitomycin C (MMC), as measured by cell killing, sister chromatid exchange, and chromosome aberrations."( Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents.
Allan, JM; Dreslin, AJ; Engelward, BP; Samson, LD; Tomasz, M; Wyatt, MD, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
3-methylguanineA methylguanine carrying the methyl substituent at position 3.
3-methylguanineA methylguanine carrying the methyl substituent at position 3.
3-methylguanineA methylguanine carrying the methyl substituent at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (43.75)18.7374
1990's6 (37.50)18.2507
2000's2 (12.50)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.54 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]